LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m1823b6dba3bd2c6865bae4f3d4ee40e5
OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Explain the results of gene expression blood tests, (2) Discuss the differences between cell-free DNA tests and gene, (3) Incorporate molecular testing into your practice expression tests.
FACULTY DISCLOSURE: John Friedewald, MD, is a consultant/speaker bureau /advisor and/or grant support for Eurofins, Transplant Genomics, Viracor, Regeneron, HANSA BioPharma, Veloxis, egenesis, and Sanofi Companies.
PLANNER DISCLOSURE: James Trotter, MD, Sumeet Asrani, MD, Gregory McKenna, MD, and Kathy Brown, RN, CCTC, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CEPTC Credit: The American Board for Transplant Certification (ABTC) has been applied for educational offering for up to 1 Category 1 Continuing Education Point for Transplant Certification (CEPTCs).
For information, please contact Karina Pena at karina.pena@bswhealth.org
- 1.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance